1. Hassewander O, Young IS. Oxidative stress in
chronic renal failure. Free Radic Res, 1998; 29:
1-11.
2. Mohora M, Mircescu G, Cirjan C, Mihaliescu I,
Girneata L, Ursea N, Dinu V. Effect of
hemodialysis on lipid peroxidation and
antioxidant system in patients with chronic
renal failure. Rom J Intern Med 1995; 33: 237-
242.
3. Haklar G, Yeğenağa I, Yalçın AS. Evaluation of
oxidant stress in chronic hemodialysis patients:
use of different parameters. Clin Chim Acta
1995; 234: 109-114.
4. Usberti M, Lima G, Arisi M, Bufano G,
DAvanzo L, Gazzotti RM. Effect of exegenous
reduced glutathione on the survival of red blood
cells in hemodialysed patients. J Nephrol 1997;
10: 261-265.
5. Loughrey CM, Young IS, Lightbody JH,
McMaster D, McNamee PT, Trimble ER.
Oxidative stress in hemodialysis. QJM, 1994;
87: 679-683.
6. Buege JA, Aust SD. Microsomal lipid
peroxidation. Methods Enzymol 1978; 12:302-
310.
7. Sun Y, Oberley LW, Li YA. Simple method for
clinical assay of superoxide dismutase. Clin
Chem.1988: 34: 497-500.
8. Beutler E, Duran O, Kelly BM. Improved
method for the determination of blood
glutathione. J Lab Clin Med 1963; 61:882-888.
9. Seymen O, Seven A, Candan G, Yiğit G, Hatemi
S, Hatemi H. The effect of iron supplementation
on GSH levels, GSH-Px, and SOD activities of
erythrocytes in L-Thyroxine administration.
Acta Med Okayama 1997; 51: 129-133.
10.Paglia DE, Valentine WN. Studies on the
quantitative and qualitative characterization of
erythrocyte glutathione peroxidase. J Lab Clin
Med 1967; 70: 158.
11.Paul JL, Sall ND, Soni T, Poignet JL,
Lindenbaum A, Man NK, Moatti N, Raichvarg
D. Lipid peroxidation abnormalities in
hemodialyzed patients. Nephron, 1993; 64: 106-
109.
12.Durak I, Akyol Ö, Başeşme E, Canbolat O, Kavut
çu M. Reduced erythrocyte defense
mechanisms against free radical toxicity in
patients with chronic renal failure. Nephron,
1994; 66:76-80.
13. Westhuyzen J, Adams CE, Fleming SJ.
Evidence for oxidative stress during in vitro
dialysis. Nephron, 1995; 70: 49-54.
14.Sanaka T, Higuchi C, Shinobe T, Nishimura H,
Omata M, Nihei H, Sugino N. Lipid
peroxidation as an indicater of biocompatibility
in hemodialysis. Nephrol Dial Transplant 1995;
10 [Suppl. 3]: 34-38.
15.Richard MJ, Arnaud J, Jurkovitz C, Hachache
T, Meftahi H, Laporte F, Foret M, Favier A,
Cordonnier D. Trace elements and lipid
peroxidation abnormalities in patients with
chronic renal failure. Nephron 1991; 57:10-15.
16.Delmas-Beauvieux MC, Combe C, Peuchant E,
Carbonneau MA, Dubourg L, de Precigout V,
Aparicio M, Clerc M. Evaluation of red blood cell
lipo-peroxidation in hemodialysed patients
during erythropoietin therapy supplemented or
not with iron. Nephron 1995; 69:404-410.
17.Hosokawa S., Yoshida O.: Effects of
erythropoietin on trace elements in patients
with chronic renal failure undergoing
hemodialysis. Nephron 1993; 65:414-417.
18. Witko-Sarsat V, Friedlander M, Capeillere-
Blandin C, Nguyen-Khoa T, Nguyen AT,
Zingraff J, Jungers P, Descamps-Latscha B.
Advanced oxidation protein products as a novel
marker of oxidative stress in uremia. Kidney
International 1996; 49: 1304-1313.
19. Paskalev D, Tchankova P, Jankova T, Steiner
M, Nenov D. Alteration in red blood cell sodium
and potassium concentrations and increased
lipid peroxidation in patients with chronic renal
failure on maintenance hemodialysis: A
hypothesis. Am J Nephrol 1994; 14: 246-248.
20.Vaziri ND, Oveisi F, Ding Y. Role of increased
oxygen free radical activity in the pathogenesis
of uremic hypertension. Kidney International
1998; 53: 1748-1754.
21.Hagen TM, Aw TY, Jones DP. Glutathione
uptake and protection against oxidative injury
in isolated kidney cells. Kidney International
1988; 34: 74-81.
